Q2 2022 Holdings
Filed 2022-08-15 | 35 holdings | $202.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $63.9M | 3,000,000 | 31.6% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $43.0M | 2,305,558 | 21.3% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $37.5M | 1,948,214 | 18.6% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $17.6M | 2,485,638 | 8.7% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $12.4M | 1,642,210 | 6.1% |
| Annexon Inc(ANNX) | COM | 03589W102 | $12.2M | 3,241,628 | 6.0% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $8.5M | 600,523 | 4.2% |
| Adagio Therapeutics Inc(IVVD) | COM | 00534A102 | $6.4M | 1,937,207 | 3.1% |
| Springworks Therapeutics Inc | COM | 85205L107 | $118.9K | 4,831,307 | 0.1% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $105.9K | 8,415,000 | 0.1% |
| Pharvaris N V(PHVS) | COM | N69605108 | $70.3K | 3,180,601 | 0.0% |
| Eqrx Inc | COM | 26886C107 | $46.9K | 10,003,573 | 0.0% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $46.5K | 3,428,014 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $40.0K | 8,663,673 | 0.0% |
| Rapid Micro Biosystems Inc(RPID) | CLASS A COM | 75340L104 | $36.3K | 8,434,560 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $24.2K | 2,647,473 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $23.1K | 1,822,883 | 0.0% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $18.6K | 1,408,901 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $17.9K | 2,260,572 | 0.0% |
| Savara Inc(SVRA) | COM | 805111101 | $17.7K | 11,622,598 | 0.0% |
| Research Alliance Corp II | COM CL A | 760873109 | $9.8K | 1,000,000 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $8.7K | 1,921,790 | 0.0% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $8.2K | 2,805,413 | 0.0% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $6.9K | 1,431,058 | 0.0% |
| Arya Sciences Acqu Corp IV | CL A | G31659108 | $6.9K | 700,000 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $6.0K | 6,264,420 | 0.0% |
| Nautilus Biotechnology Inc(NAUT) | COM | 63909J108 | $5.4K | 2,000,000 | 0.0% |
| Aptinyx Inc | COM | 03836N103 | $5.0K | 8,891,758 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $4.9K | 7,929,918 | 0.0% |
| Panacea Acquisition Corp II | CL A SHS | G6882C106 | $4.9K | 500,000 | 0.0% |
| Arya Sciences Acquisitn Corp | CLASS A ORD SHS | G31658100 | $4.9K | 500,000 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $4.8K | 487,500 | 0.0% |
| Frazier Lifesciences Acqu Co | UNIT 12/09/2025 | G3710A121 | $3.0K | 300,000 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $2.9K | 3,019,540 | 0.0% |
| Aeglea Biotherapeutics Inc(AGLEUSD) | COM | 00773J103 | $2.7K | 5,347,689 | 0.0% |